Cook Katherine L, Schwartz-Roberts Jessica L, Baumann William T, Clarke Robert
Department of Oncology and Lombardi Comprehensive Cancer Center; Georgetown University Medical Center, Washington, DC USA; Department of Surgery, Hypertension and Vascular Research Center, Wake Forest Comprehensive Cancer Center; Wake Forest University, Winston-Salem, NC USA.
Department of Oncology and Lombardi Comprehensive Cancer Center; Georgetown University Medical Center , Washington, DC USA.
Mol Cell Oncol. 2015 Apr 14;3(1):e1023928. doi: 10.1080/23723556.2015.1023928. eCollection 2016 Jan.
Resistance to antiestrogen therapy remains a critical determinant of mortality in patients affected by ER+ breast cancer. Our previous work identified autophagy and interferon regulatory factor 1 (IRF1) signaling as key regulators of this process. We have recently demonstrated a novel reciprocal interaction between IRF1 and ATG7, linking inflammation and autophagy.
抗雌激素治疗耐药仍然是雌激素受体阳性(ER+)乳腺癌患者死亡率的关键决定因素。我们之前的研究确定自噬和干扰素调节因子1(IRF1)信号传导是这一过程的关键调节因子。我们最近证明了IRF1与自噬相关基因7(ATG7)之间存在一种新的相互作用,将炎症与自噬联系起来。